These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 17344278)
1. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Hutchinson C; Geissler CA; Powell JJ; Bomford A Gut; 2007 Sep; 56(9):1291-5. PubMed ID: 17344278 [TBL] [Abstract][Full Text] [Related]
2. Post-prandial iron absorption in humans: comparison between HFE genotypes and iron deficiency anaemia. Hutchinson C; Conway RE; Bomford A; Hider RC; Powell JJ; Geissler CA Clin Nutr; 2008 Apr; 27(2):258-63. PubMed ID: 18276042 [TBL] [Abstract][Full Text] [Related]
3. Proton Pump Inhibitors Decrease Phlebotomy Need in HFE Hemochromatosis: Double-Blind Randomized Placebo-Controlled Trial. Vanclooster A; van Deursen C; Jaspers R; Cassiman D; Koek G Gastroenterology; 2017 Sep; 153(3):678-680.e2. PubMed ID: 28624580 [TBL] [Abstract][Full Text] [Related]
4. Absorption of nonheme iron during gastric acid suppression in patients with hereditary hemochromatosis and healthy controls. Moris W; Verhaegh PLM; Verbeek J; Swinkels DW; Laarakkers CM; Masclee AAM; Koek GH; Deursen CTBMV Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1105-G1110. PubMed ID: 33949198 [TBL] [Abstract][Full Text] [Related]
5. The modified iron avidity index: a promising phenotypic predictor in HFE-related haemochromatosis. Verhaegh PL; Moris W; Koek GH; van Deursen CT Liver Int; 2016 Oct; 36(10):1535-9. PubMed ID: 26992127 [TBL] [Abstract][Full Text] [Related]
6. Proton Pump Inhibitors Reduce the Frequency of Phlebotomy in Patients With Hereditary Hemochromatosis. van Aerts RM; van Deursen CT; Koek GH Clin Gastroenterol Hepatol; 2016 Jan; 14(1):147-52. PubMed ID: 26240005 [TBL] [Abstract][Full Text] [Related]
7. Serum prohepcidin concentration: no association with iron absorption in healthy men; and no relationship with iron status in men carrying HFE mutations, hereditary haemochromatosis patients undergoing phlebotomy treatment, or pregnant women. Roe MA; Spinks C; Heath AL; Harvey LJ; Foxall R; Wimperis J; Wolf C; Fairweather-Tait SJ Br J Nutr; 2007 Mar; 97(3):544-9. PubMed ID: 17313717 [TBL] [Abstract][Full Text] [Related]
8. HFE genotypes and dietary heme iron: no evidence of strong gene-nutrient interaction on serum ferritin concentrations in middle-aged women. van der A DL; Peeters PH; Grobbee DE; Roest M; Voorbij HA; van der Schouw YT Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):60-8. PubMed ID: 16399493 [TBL] [Abstract][Full Text] [Related]
9. The iron-chelating potential of silybin in patients with hereditary haemochromatosis. Hutchinson C; Bomford A; Geissler CA Eur J Clin Nutr; 2010 Oct; 64(10):1239-41. PubMed ID: 20628405 [TBL] [Abstract][Full Text] [Related]
10. Increased DMT1 but not IREG1 or HFE mRNA following iron depletion therapy in hereditary haemochromatosis. Kelleher T; Ryan E; Barrett S; Sweeney M; Byrnes V; O'Keane C; Crowe J Gut; 2004 Aug; 53(8):1174-9. PubMed ID: 15247188 [TBL] [Abstract][Full Text] [Related]
11. Effect of procyanidin on dietary iron absorption in hereditary hemochromatosis and in dysmetabolic iron overload syndrome: A crossover double-blind randomized controlled trial. Lobbes H; Gladine C; Mazur A; Pereira B; Dualé C; Cardot JM; Ruivard M Clin Nutr; 2020 Jan; 39(1):97-103. PubMed ID: 30792142 [TBL] [Abstract][Full Text] [Related]
12. Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Kaltwasser JP; Werner E; Schalk K; Hansen C; Gottschalk R; Seidl C Gut; 1998 Nov; 43(5):699-704. PubMed ID: 9824354 [TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors reduce phlebotomy burden in patients with HFE-related hemochromatosis: a systematic review and meta-analysis. Dirweesh A; Anugwom CM; Li Y; Vaughn BP; Lake J Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1327-1331. PubMed ID: 32769410 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases. Welage LS; Berardi RR J Am Pharm Assoc (Wash); 2000; 40(1):52-62; quiz 121-3. PubMed ID: 10665250 [TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors: better acid suppression when taken before a meal than without a meal. Hatlebakk JG; Katz PO; Camacho-Lobato L; Castell DO Aliment Pharmacol Ther; 2000 Oct; 14(10):1267-72. PubMed ID: 11012470 [TBL] [Abstract][Full Text] [Related]
17. The effect of a natural polyphenol supplement on iron absorption in adults with hereditary hemochromatosis. Buerkli S; Salvioni L; Koller N; Zeder C; Teles MJ; Porto G; Habermann JH; Dubach IL; Vallelian F; Frey BM; Moretti D; Baumgartner J; Zimmermann MB Eur J Nutr; 2022 Sep; 61(6):2967-2977. PubMed ID: 35320401 [TBL] [Abstract][Full Text] [Related]
18. How I treat hemochromatosis. Adams PC; Barton JC Blood; 2010 Jul; 116(3):317-25. PubMed ID: 20308595 [TBL] [Abstract][Full Text] [Related]
19. Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy. Stewart CA; Termanini B; Sutliff VE; Serrano J; Yu F; Gibril F; Jensen RT Aliment Pharmacol Ther; 1998 Jan; 12(1):83-98. PubMed ID: 9692706 [TBL] [Abstract][Full Text] [Related]
20. The pharmacology and clinical relevance of proton pump inhibitors. Katz PO; Frissora C Curr Gastroenterol Rep; 2002 Dec; 4(6):459-62. PubMed ID: 12441035 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]